Hello,

We noticed you're browsing in private or incognito mode.

To continue reading this article, please exit incognito mode or log in.

Not an Insider? Subscribe now for unlimited access to online articles.

Rewriting Life

Scaffolds for Stem Cells

Despite the high hopes surrounding stem cells’ potential to form replacement tissue for medical use, biologists are still struggling in the lab to get these finicky cells to transform into the needed tissues. Now Cartilix, a startup in San Carlos, CA, is offering a technology that might help: polymer materials that direct the growth and development of stem cells.

The startup is working on polymer gels that would be implanted into the joints of arthritic patients and serve as scaffolds upon which the patients’ own bone marrow stem cells would form new cartilage. The stem cells would come from the blood that naturally seeps into the joint area during the implantation procedure; after new tissue forms, the polymer would biodegrade. The hope is that this treatment will help patients “get their own cartilage back” and avoid joint replacement surgery, says Frank Huerta, Cartilix’s CEO.

Stem cells require cues from their environment – including growth factors secreted by other cells and even mechanical pulling forces – in order to transform into more mature and specialized cells and tissue. Scaffolds can provide those cues, says Jennifer Elisseeff, a biomedical-engineering professor at Johns Hopkins University and Cartilix’s scientific cofounder. With these scaffolds, “our goal is to mimic what the cells normally see in the body,” she says. Cartilix’s gels, for example, would be infused with growth factors that encourage the growth of the right kinds of cartilage.

This story is part of our December 2004 Issue
See the rest of the issue
Subscribe

Cartilix isn’t the only group combining polymers with stem cells. MIT researchers are growing human embryonic stem cells on hundreds of polymer materials to test their interactions (see photo). But Cartilix stands out because its treatments wouldn’t involve cell transplants; rather, the polymer would prompt the patient’s own cells to form new tissue. Stem-cell-based treatments remain years away, but Cartilix and its competitors may have provided a scaffold they can grow on.

Tech Obsessive?
Become an Insider to get the story behind the story — and before anyone else.

Subscribe today

Uh oh–you've read all of your free articles for this month.

Insider Premium
$179.95/yr US PRICE

More from Rewriting Life

Reprogramming our bodies to make us healthier.

Want more award-winning journalism? Subscribe to Insider Online Only.
  • Insider Online Only {! insider.prices.online !}*

    {! insider.display.menuOptionsLabel !}

    Unlimited online access including articles and video, plus The Download with the top tech stories delivered daily to your inbox.

    See details+

    What's Included

    Unlimited 24/7 access to MIT Technology Review’s website

    The Download: our daily newsletter of what's important in technology and innovation

/
You've read all of your free articles this month. This is your last free article this month. You've read of free articles this month. or  for unlimited online access.